omniture

WuXi PharmaTech (NYSE: WX) Endows a New Faculty Position at Tongji University

2008-04-16 19:22 830

SHANGHAI, China, April 16 /Xinhua-PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced it endowed a new professor position in the Medical and Life Science School of Tongji University.

(Logo: http://www.prnasia.com/sa/200708281726.jpg )

Dr. Gang Pei, President of Tongji University, Dr. Jian Fei, Deputy Dean of the Medical and Life Science School of Tongji University, Dr. Ge Li, Chairman and CEO of WuXi PharmaTech and other company representatives attended the endowment ceremony on April 9, 2008. The endowed professor position will be filled by people selected from accomplished scholars and professors in medical, pharmaceutical and biological fields around the world.

Tongji University ( http://www.tongji.edu.cn/english/inc/index.asp ), whose history can be traced back to 1907 when Tongji German Medical School was founded by Erich Paulun, a German doctor in Shanghai, is one of the leading universities in China. The name Tongji suggests cooperating by riding the same boat.

Commenting on WuXi PharmaTech’s endowment, Dr. Pei said, “WuXi PharmaTech, one of the most successful enterprises, has made widely-recognized achievements and showcased strong pharmaceutical R&D power in China. WuXi’s generosity not only helps our research and teaching activities, but also creates a new industry-academia collaboration model that will attract more talents and make a positive impact on the domestic pharmaceutical industry.”

“We are very happy and honored to establish such a professor position for Tongji University. As a global leading pharmaceutical, biotechnology and medical device R&D outsourcing company, WuXi strives to be a good corporate citizen. Through the endowment WuXi and Tongji University together are charting a course for stimulating and promoting China’s pharmaceutical R&D,” commented Dr. Ge Li, Chairman and CEO of WuXi PharmaTech.

About WuXi PharmaTech

WuXi PharmaTech, headquartered in Shanghai, China, is the leading global pharmaceutical, biotechnology and medical device R&D outsourcing company. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies a broad and integrated portfolio of laboratory, research manufacturing, biologics testing and manufacturing services throughout the drug and medical device research and development process. WuXi PharmaTech’s services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device research and development by providing cost-effective and efficient outsourcing solutions that save its customers both time and money. For more information, please visit: http://www.wuxipharmatech.com .

Source: WuXi PharmaTech
Related Stocks:
NYSE:WX
collection